Angel Yeast announced that the company's second extraordinary shareholders' meeting in 2026 reviewed and passed the “Proposal on the Enzyme Formulation Company's New Synthetic Biology Pilot Verification Base Project”. A total of 799 shareholders and agents attended the meeting. The total number of voting shares held was 464 million, accounting for 53.44% of the company's total voting shares. The conference calling, holding and voting procedures complied with relevant regulations, and Beijing Commerce Law Firm witnessed and issued legal and effective opinions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.